Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery
Status:
Completed
Trial end date:
2017-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate superior efficacy of DE-108 ophthalmic solution to
that of Levofloxacin 0.5% ophthalmic solution as well as safety of the former used for
perioperative bacteria eradication in patients who are scheduled for cataract surgery.